Drug major Pfizer Inc. (PFE) announced Monday positive topline results from the progression-free survival or PFS analysis of the ...

Erasca, Inc. (NASDAQ:ERAS – Get Free Report)’s share price shot up 6.6% during mid-day trading on Friday . The stock traded as high as $1.97 and last traded at $2.01. 459,262 shares changed hands ...

SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with ...

PAR Technology Corporation ("PAR") has been at the forefront of helping restaurants transform operational challenges into opportunities. With the launch of PAR OPS, PAR connects the proven back-office ...

Lenovo is proud to announce that it has achieved all six Microsoft Solutions Partner Designations under the Microsoft AI Cloud Partner Program. This recognition underscores Lenovo's technical ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous ...

Erasca is a biotech company focused on developing therapies for RAS/MAPK pathway-driven cancers with a strong financial ...

This study presents fundamental insights into overcoming resistance in hormone receptor-positive breast cancer by demonstrating that sustained CDK4/6 inhibitor treatment, either alone or in ...